Inter- and intra-person cytomegalovirus infection in Malawian families

Journal of Medical Virology

Volumn 75, Issue 4, 2005, Pages 575-582

  Beyari, Mohammed M ^a,b   Hodgson, T A ^a   Kondowe, W ^c   Molyneux, E M ^c   Scully, C ^a   Porter, S R ^a   Teo, C G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Africa; Cytomegalovirus; Molecular epidemiology; Oral; Transmission; Urine

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FAMILY STUDY; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GN GENE; GO GENE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KAPOSI SARCOMA; LAVAGE; MALAWI; MALE; MOUTH; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEROEPIDEMIOLOGY; URINALYSIS; VIRUS GENE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; INFANT; MALAWI; MALE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MOUTH; PHYLOGENY; SARCOMA, KAPOSI; SEQUENCE ANALYSIS, DNA; URINE; VIRAL ENVELOPE PROTEINS;

EID: 14344262550     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20312     Document Type: Article

References (41)

1. Adler SP. 1989. Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N Engl J Med 321:1290-1296.
2. Alberola J, Tamarit A, Igual R, Navarro D. 2000. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection. J Clin Virol 16:113-122.
3. Aynaud O, Poveda JD, Huynh B, Guillemotonia A, Barrasso R. 2002. Frequency of herpes simplex virus, cytomegalovirus and human papillomavirus DNA in semen. Int J STD AIDS 13:547-550.
4. Bale JF, Jr., Petheram SJ, Robertson M, Murph JR, Demmler G. 2001. Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 65:90-96.
5. Bar M, Shannon-Lowe C, Geballe AP. 2001. Differentiation of human cytomegalovirus genotypes in immunocompromised patients on the basis of UL4 gene polymorphisms. J Infect Dis 183:218-225.
6. Bello CS. 1992. Transmission of cytomegalovirus in the Gambia. West Afr J Med 11:140-145.
7. Beyari MM, Hodgson TA, Cook RD, Kondowe W, Molyneux EM, Scully CM, Teo CG, Porter SR. 2003. Multiple human herpesvirus-8 infection. J Infect Dis 188:678-689.
8. Bryant P, Morley C, Garland S, Curtis N. 2002. Cytomegalovirus transmission from breast milk in premature babies: Does it matter? Arch Dis Child Fetal Neonatal 87:F75-F77.
9. Chandler SH, Handsfield HH, McDougall JK. 1987. Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J Infect Dis 155:655-660.
10. Chou S. 1992a. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis 166:604-607.
11. Chou S. 1992b. Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 188:388-390.
12. Collier AC, Chandler SH, Handsfield HH, Corey L, McDougall JK. 1989. Identification of multiple strains of cytomegalovirus in homosexual men. J Infect Dis 159:123-126.
13. Collier AC, Handsfield HH, Ashley R, Roberts PL, DeRouen T, Meyers JD, Corey L. 1995. Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 171:33-38.
14. Cook RD, Hodgson TA, Waugh AC, Molyneux EM, Borgstein E, Sherry A, Teo CG, Porter SR. 2002. Mixed patterns of transmission of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) in Malawian families. J Gen Virol 83:1613-1619.
15. de Mattia D, Stroffolini T, Arista S, Pistoia D, Giammanco A, Maggio M, Chiaramonte M, Moschen ME, Mura I, Rigo G. 1991. Prevalence of cytomegalovirus infection in Italy. Epidemiol Infect 107:421-427.
16. de Ory F, Ramirez R, Garcia Comas L, Leon P, Sagues MJ, Sanz JC. 2004. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 19:85-89.
17. Fidouh-Houhou N, Duval X, Bissuel F, Bourbonneux V, Flandre P, Ecobichon JL, Jordan MC, Vilde JL, Brun-Vezinet F, Leport C. 2001. Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 33:1406-1411.
18. Griffiths PD. 2002. Strategies to prevent CMV infection in the neonate. Semin Neonatol 7:293-299.
19. Hitomi S, Kozuka-Hata H, Chen Z, Sugano S, Yamaguchi N, Watanabe S. 1997. Human cytomegalovirus open reading frame UL11 encodes a highly polymorphic protein expressed on the infected cell surface. Arch Virol 142:1407-1427.
20. Kari B, Gehrz R. 1992. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J Virol 66:1761-1764.
21. Kashiwagi Y, Nemoto S, Hisashi, Kawashima, Takekuma K, Matsuno T, Hoshika A, Nozaki-Renard J. 2001. Cytomegalovirus DNA among children attending two day-care centers in Tokyo. Pediatr Int 43:493-495.
22. Krech U, Tobin J. 1981. A collaborative study of cytomegalovirus antibodies in mothers and young children in 19 countries. Bull World Health Organ 59:605-610.
23. Lasry S, Deny P, Asselot C, Rauzy M, Boucher J, Guyot C, Leroux MC, Livartowski A, Reinert P, Nicolas JC. 1996. Interstrain variations in the cytomegalovirus (CMV) glycoprotein B gene sequence among CMV-infected children attending six day care centers. J Infect Dis 174:606-609.
24. Ling PD, Ryon JJ, Hayward SD. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J Viro 167:2990-3003.
25. Mach M, Kropff B, Dal Monte P, Britt W. 2000. Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73). J Virol 74:11881-11892.
26. Mattick C, Dewin D, Polley S, Sevilla-Reyes E, Pignatelli S, Rawlinson W, Wilkinson G, Dal Monte P, Gompels UA. 2004. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 318:582-597.
27. Miller WE, Edwards RH, Walling DM, Raab-Traub N. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75:2729-2740.
28. Mostad SB, Kreiss JK, Ryncarz AJ, Overbaugh J, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo JJ, Corey L, Mostad SB, Kreiss JK, Ryncarz AJ, Overbaugh J, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo JJ, Corey L. 1999. Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infectedwomen. J Med Virol 59:469-473.
29. Pass RF. 2001. Cytomegalovirus. In: Knipe DM, Holey PM, editors. Field's virology. Philadelphia: Lippincott Williams & Wilkins. pp 2675-2704.
30. Pass RF, Hutto C, Ricks R, Cloud GA. 1986. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med 314:1414-1418.
31. Paterson DA, Dyer AP, Milne RS, Sevilla-Reyes E, Gompels UA. 2002. A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology 293:281-294.
32. Pignatelli S, Dal Monte P, Landini MP. 2001. gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol 82:2777-2784.
33. Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, Guo JJ, Rawlinson W, Britt W, Mach M, Landini MP. 2003. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 84:647-655.
34. Plotkin SA. 2002. Is there a formula for an effective CMV vaccine? J Clin Virol 25:S13-S21.
35. Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. 2002. The genes encoding the GCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol 76:10841-10848.
36. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. 2002. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 186:553-557.
37. Stebbing J, Bourboulia D, Johnson M, Henderson S, Williams I, Wilder N, Tyrer M, Youle M, Imami N, Kobu T, Kuon W, Sieper J, Gotch F, Boshoff C. 2003. Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. J Virol 77:4306-4314.
38. Stroffolini T, Ngatchu T, Chiaramonte M, Giammanco A, Maggio M, Sarzana A, Taormina S. 1993. Prevalence of cytomegalovirus seropositivity in an urban childhood population in Cameroon. New Microbiol 16:83-85.
39. Verbraak FD, Bruinenberg M, van den Horn GJ, Meenken C, van der Lelij A, Hoyng CB, Kijlstra A, Peek R. 1998. Cytomegalovirus (CMV) strain differences between the eye and blood in AIDS patients with CMV retinitis. AIDS 12:713-718.
40. Wojcicki JM. 2003. Traditional behavioural practices, the exchange of saliva and HHV-8 transmission in sub-Saharan African populations. Br J Cancer 89:2016-2017.
41. Zong JC, Ciufo DM, Alcendor DJ, Wan X, Nicholas J, Browning PJ, Rady PL, Tyring SK, Orenstein JM, Rabkin CS, Su IJ, Powell KF, Croxson M, Foreman KE, Nickoloff BJ, Alkan S, Hayward GS. 1999. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73:4156-4170.